Indivior CEO and CFO receive base salary increases effective Jan 1, 2026

Indivior Pharmaceuticals, Inc.

CEO Joseph Ciaffoni salary increased from $1,050,000 to $1,115,000.
CFO Ryan Preblick salary increased from $559,000 to $604,000.
Changes effective January 1, 2026, approved by Board on Dec 12, 2025.
Based on competitive market review and Compensation Committee recommendation.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001625297-25-000076
form_type: 8-K
ticker: INDV
cik: 0001625297
company_name: Indivior Pharmaceuticals, Inc.
filed_at: 2025-12-18T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.966588+00:00
generated_at: 2026-05-16T12:44:51.276324+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001625297-25-000076
json_url: https://secwatch.observer/filing/0001625297-25-000076.json
markdown_url: https://secwatch.observer/filing/0001625297-25-000076.md
text_url: https://secwatch.observer/filing/0001625297-25-000076.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000076/0001625297-25-000076-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000076/indv-20251212.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001625297-25-000076

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.